title: Methadone: a substrate and mechanism-based inhibitor of CYP19 (aromatase).
abstract: The peripheral conversion of testosterone to estradiol by aromatase is the primary source of endogenous estrogen in postmenopausal women. Studies indicating that placental aromatase is able to metabolize methadone to its primary metabolite, 2-ethylidene-1, 5-dimethyl-3, 3-diphenylpyrrolidin (EDDP), led us to test the hypothesis that methadone is able to act as an inhibitor of aromatase. Using recombinant human CYP19, we examined the ability of methadone to bring about either reversible or mechanism-based inhibition of the conversion of testosterone to estradiol. To test for reversible inhibition, racemic methadone or its metabolite EDDP or 2-ethyl-5-methyl-3, 3-diphenylpyrroline (EMDP) was incubated for 30 min with testosterone at the K(m) (4 microM). To test for mechanism-based inhibition, microsomal preincubations were performed for up to 30 min using racemic methadone (1-1000 microM), R- or S-methadone (0.5-500 microM), or EDDP or EMDP (10 and 100 microM) followed by incubation with testosterone at a V(max) concentration (50 microM). Racemic methadone, EDDP, and EMDP did not act as competitive inhibitors of CYP19. Preincubation of methadone, EDDP, or EMDP with CYP19 resulted in time- and concentration-dependent inhibition, indicating a mechanism-based reaction that destroys CYP19 activity. The K(I) and k(inact) values for racemic methadone were calculated to be 40.6 +/- 2.8 microM and 0.061 +/- 0.001 min(-1), respectively. No stereoselectivity was observed. Methadone is metabolized by CYP19 and may act as a potent inhibitor of CYP19 in vivo. These findings may contribute to variability in methadone clearance, to drug-drug interactions, and to side effects observed in individual patients.
authors.affiliation: Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. lu20@iupui.edu
authors.forename: Wenjie Jessie
authors.initials: WJ
authors.lastname: Lu
authors.forename: Robert
authors.initials: R
authors.lastname: Bies
authors.forename: Landry K
authors.initials: LK
authors.lastname: Kamden
authors.forename: Zeruesenay
authors.initials: Z
authors.lastname: Desta
authors.forename: David A
authors.initials: DA
authors.lastname: Flockhart
mesh_terms: D000701:Analgesics, Opioid / Q000378:metabolism / Q000494:pharmacology; D000728:Androgens / Q000378:metabolism; D001141:Aromatase / Q000378:metabolism*; D047072:Aromatase Inhibitors / Q000378:metabolism / Q000494:pharmacology*; D004958:Estradiol / Q000378:metabolism; D004967:Estrogens / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D008691:Methadone / Q000378:metabolism* / Q000494:pharmacology*; D008861:Microsomes / Q000378:metabolism; D011759:Pyrrolidines / Q000378:metabolism; D011994:Recombinant Proteins / Q000378:metabolism; D013739:Testosterone / Q000378:metabolism
chemical_list: C103254:2-ethyl-5-methyl-3,3-diphenylpyrroline; D000701:Analgesics, Opioid; D000728:Androgens; D047072:Aromatase Inhibitors; D004967:Estrogens; D011759:Pyrrolidines; D011994:Recombinant Proteins; D013739:Testosterone; D004958:Estradiol; D001141:Aromatase; D008691:Methadone; C010724:2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine
references.citation: JAMA. 2008 Nov 19;300(19):2303-5
references.pmid: 19017918
references.citation: Drug Alcohol Depend. 2000 Dec 22;61(1):47-54
references.pmid: 11064183
references.citation: Am J Perinatol. 2006 Jul;23(5):287-94
references.pmid: 16799915
references.citation: Int J Androl. 2009 Apr;32(2):131-9
references.pmid: 17971165
references.citation: Curr Drug Metab. 2007 Jun;8(5):407-47
references.pmid: 17584015
references.citation: Clin Pharmacokinet. 2002;41(14):1153-93
references.pmid: 12405865
references.citation: Br J Clin Pharmacol. 2009 Jan;67(1):29-37
references.pmid: 19133059
references.citation: Am J Forensic Med Pathol. 1995 Jun;16(2):97-100
references.pmid: 7572883
references.citation: Biochem Pharmacol. 2006 Apr 14;71(8):1255-64
references.pmid: 16455059
references.citation: Br J Clin Pharmacol. 1999 Apr;47(4):403-12
references.pmid: 10233205
references.citation: Int J Addict. 1985 Jun-Jul;20(6-7):803-21
references.pmid: 3908338
references.citation: J Pharmacol Exp Ther. 2003 Sep;306(3):1099-105
references.pmid: 12808001
references.citation: Drug Metab Dispos. 2003 Jun;31(6):742-7
references.pmid: 12756206
references.citation: Anesthesiology. 2008 Mar;108(3):363-74
references.pmid: 18292673
references.citation: N Engl J Med. 2005 May 26;352(21):2211-21
references.pmid: 15917386
references.citation: Clin Pharmacol Ther. 2008 Oct;84(4):497-505
references.pmid: 19238655
references.citation: Ciba Found Symp. 1995;191:171-80; discussion 180-6
references.pmid: 8582196
references.citation: J Pharmacol Exp Ther. 1999 Sep;290(3):1116-25
references.pmid: 10454485
references.citation: Life Sci. 1981 May 11;28(19):2111-7
references.pmid: 7253804
references.citation: Pharmacotherapy. 2003 Jun;23(6):802-5
references.pmid: 12820821
references.citation: J Med Chem. 1971 Mar;14(3):194-7
references.pmid: 5552207
references.citation: Toxicology. 1997 Feb 14;117(1):13-23
references.pmid: 9020195
references.citation: J Pharmacol Exp Ther. 1985 Apr;233(1):1-6
references.pmid: 3981450
references.citation: J Biomed Inform. 2007 Aug;40(4):382-9
references.pmid: 17185042
references.citation: Drug Alcohol Depend. 2006 Dec 1;85(3):258-62
references.pmid: 16860495
references.citation: Acta Anaesthesiol Scand. 2008 Aug;52(7):879-89
references.pmid: 18331375
references.citation: Chem Res Toxicol. 2008 Jan;21(1):189-205
references.pmid: 18052110
references.citation: Clin Pharmacol Ther. 2004 Sep;76(3):250-69
references.pmid: 15371986
references.citation: J Steroid Biochem Mol Biol. 1997 Apr;61(3-6):117-26
references.pmid: 9365180
references.citation: Pain Med. 2008 Apr;9(3):315-44
references.pmid: 18386306
references.citation: Anesthesiology. 2009 Mar;110(3):660-72
references.pmid: 19225389
references.citation: Indian J Pediatr. 2008 Sep;75(9):911-4
references.pmid: 18584128
references.citation: Biochem Pharmacol. 2004 Aug 1;68(3):583-91
references.pmid: 15242824
references.citation: Arch Biochem Biophys. 1981 Sep;210(2):717-28
references.pmid: 7305355